Private Equity

Lennard Keijzer
Arne Grimme
Pete Lawley
+ 36 other experts

Expertise across the full lifecycle of private equity matters

The fast-changing nature of private equity transactions requires an agile full-service private equity practice. From fundraising and initial investments to exit transactions and closing down of the fund, and everything else that arises en route - our clients can count on strategic thinkers who offer creative solutions, and who understand their financial and commercial interests. This perspective, combined with our extensive experience, global presence and cross-practice approach with experts in all relevant areas, enables us to deliver appreciable added value for our clients.

We advise private equity funds, venture capital funds and other investment funds, limited partners, management teams and senior debt and mezzanine providers on their domestic and international transactions, and their legal and tax structuring.

We have in-depth knowledge in:

  • private equity transactions ranging from private acquisitions to public-to-private transactions and from complex cross-border leveraged buy-outs to venture or growth capital investments, including advice on management participation schemes and on the tax and financing aspects of those transactions; and
  • the formation and regulation of domestic and overseas private equity funds.

Recent Matters

15 June 2021

Parcom and founders sell majority stake in GoodHabitz to Prosus

De Brauw advised Parcom and GoodHabitz's founders on the sale of a majority stake in GoodHabitz to Prosus. GoodHabitz is a fast-growing provider of online-training for the corporate market with eight offices throughout Europe.
8 June 2021

Primavera Capital acquires Mead Johnson Business from Reckitt Benckiser Group

De Brauw assists Primavera Capital Group ("Primavera") in the acquisition of the infant formula and child nutrition business of Mead Johnson Nutrition Company ("Mead Johnson") in China from Reckitt Benckiser Group plc ("Reckitt") for an implied enterprise value of USD 2.2 billion. Reckitt will retain an 8% shareholding. Primavera and Reckitt have signed a definitive agreement to acquire Mead Johnson's Greater China infant formula and child nutrition business, including a manufacturing plant in Nijmegen, the Netherlands. Mead Johnson is a global leading infant formula and nutrition company. This acquisition is another milestone for Primavera in the consumer industry. Going forward, Primavera will fully support Mead Johnson's growth, through innovation, operational improvement, channel optimization, and digital transformation, to further enhance its positioning and growth prospects in China's infant nutrition market.Completion is, amongst other things, subject to works council consultation in the Netherlands. Subject to completing the works council consultation and the satisfaction of customary closing conditions, completion is expected in the second half of 2021.
4 February 2020

Apollo agrees to acquire specialty pharmaceutical company Covis Pharma BV

De Brauw has advised Apollo on the acquisition of speciality pharmaceutical company Covis Pharma.

The highly motivated team, with prominence in the private equity sphere, has made it a go-to firm for both domestic and international private equity clients.

Chambers Europe
Chambers Europe2021